These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 17123275)

  • 1. Improving follow-up to abnormal breast cancer screening in an urban population. A patient navigation intervention.
    Battaglia TA; Roloff K; Posner MA; Freund KM
    Cancer; 2007 Jan; 109(2 Suppl):359-67. PubMed ID: 17123275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Family physicians expedite diagnosis of breast disease in urban minority women.
    Ferrante JM; Rovi S; Das K; Kim S
    J Am Board Fam Med; 2007; 20(1):52-9. PubMed ID: 17204735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What factors are associated with diagnostic follow-up after abnormal mammograms? Findings from a U.S. National Survey.
    Yabroff KR; Breen N; Vernon SW; Meissner HI; Freedman AN; Ballard-Barbash R
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):723-32. PubMed ID: 15159302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of women refusing follow-up for tests or symptoms suggestive of breast cancer.
    Weinmann S; Taplin SH; Gilbert J; Beverly RK; Geiger AM; Yood MU; Mouchawar J; Manos MM; Zapka JG; Westbrook E; Barlow WE
    J Natl Cancer Inst Monogr; 2005; (35):33-8. PubMed ID: 16287883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting follow-up among low-income women with breast abnormalities.
    Kaplan CP; Crane LA; Stewart S; Juarez-Reyes M
    J Womens Health (Larchmt); 2004 Mar; 13(2):195-206. PubMed ID: 15072734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of factors potentially associated with inadequate follow-up of mammographic abnormalities.
    McCarthy BD; Yood MU; Janz NK; Boohaker EA; Ward RE; Johnson CC
    Cancer; 1996 May; 77(10):2070-6. PubMed ID: 8640672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).
    Chen AY; Halpern MT; Schrag NM; Stewart A; Leitch M; Ward E
    J Natl Cancer Inst; 2008 Apr; 100(7):462-74. PubMed ID: 18364506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health maintenance and screening in breast cancer survivors in the United States.
    Duffy CM; Clark MA; Allsworth JE
    Cancer Detect Prev; 2006; 30(1):52-7. PubMed ID: 16455209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insurance status and stage of cancer at diagnosis among women with breast cancer.
    Halpern MT; Bian J; Ward EM; Schrag NM; Chen AY
    Cancer; 2007 Jul; 110(2):403-11. PubMed ID: 17562557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial and ethnic disparities in breast cancer mortality: are we doing enough to address the root causes?
    Blackman DJ; Masi CM
    J Clin Oncol; 2006 May; 24(14):2170-8. PubMed ID: 16682736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005).
    Harper S; Lynch J; Meersman SC; Breen N; Davis WW; Reichman MC
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):121-31. PubMed ID: 19124489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disparities in mammography use among US women aged 40-64 years, by race, ethnicity, income, and health insurance status, 1993 and 2005.
    Sabatino SA; Coates RJ; Uhler RJ; Breen N; Tangka F; Shaw KM
    Med Care; 2008 Jul; 46(7):692-700. PubMed ID: 18580388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time to Diagnostic Evaluation After Mammographic Screening in an Urban Setting.
    Oppong BA; Dash C; Coleman T; Torres T; Adams-Campbell LL
    J Womens Health (Larchmt); 2016 Dec; 25(12):1225-1230. PubMed ID: 27182625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammography surveillance and mortality in older breast cancer survivors.
    Lash TL; Fox MP; Buist DS; Wei F; Field TS; Frost FJ; Geiger AM; Quinn VP; Yood MU; Silliman RA
    J Clin Oncol; 2007 Jul; 25(21):3001-6. PubMed ID: 17548838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
    Pelletier EM; Shim B; Goodman S; Amonkar MM
    Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do age and ethnicity predict breast cancer treatment received? A cross-sectional urban population based study. Breast cancer treatment: age and ethnicity.
    Naeim A; Hurria A; Leake B; Maly RC
    Crit Rev Oncol Hematol; 2006 Sep; 59(3):234-42. PubMed ID: 16829122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Provider delay among patients with breast cancer in Germany: a population-based study.
    Arndt V; Stürmer T; Stegmaier C; Ziegler H; Becker A; Brenner H
    J Clin Oncol; 2003 Apr; 21(8):1440-6. PubMed ID: 12697864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in mammography and clinical breast examination: a population-based study.
    Chagpar AB; McMasters KM
    J Surg Res; 2007 Jun; 140(2):214-9. PubMed ID: 17418862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can breast and cervical cancer screening visits be used to enhance colorectal cancer screening?
    Carlos RC; Fendrick AM; Ellis J; Bernstein SJ
    J Am Coll Radiol; 2004 Oct; 1(10):769-76. PubMed ID: 17411698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lay patient navigator program implementation for equal access to cancer care and clinical trials: essential steps and initial challenges.
    Steinberg ML; Fremont A; Khan DC; Huang D; Knapp H; Karaman D; Forge N; Andre K; Chaiken LM; Streeter OE
    Cancer; 2006 Dec; 107(11):2669-77. PubMed ID: 17078056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.